Differential effects of PD98059 and U0126 on osteogenesis and adipogenesis

被引:34
作者
Dang, ZC [1 ]
Lowik, CWGM [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2300 RC Leiden, Netherlands
关键词
estrogen; adipocyte; osteoblast; MAPKs; PPAR gamma;
D O I
10.1002/jcb.20087
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PD98059 and U0126 are considered as specific inhibitors of the p42/44 mitogen-activated protein kinases (MAPK) pathway, which affects osteogenesis and adipogenesis. Here, we show unexpected differential effects of PD98059 and U0126 on osteogenesis and adipogenesis as well as on estrogen (E2)-induced actions in osteoprogenitor KS483 cells. PD98059 dose-dependently inhibited osteogenesis indicated by cellular alkaline phosphatase (ALP) activity and nodule formation, but stimulated adipogenesis shown by the number of adipocytes. In contrast, U0126 slightly decreased osteogenesis but had no effects on adipogenesis, although it inhibited p42/44 MAPK more potently than PD98059. Furthermore, PD98059, but not U0126, counteracted E2-induced osteogenesis and adipogenesis. Transfection experiments showed that PD98059, but not U0126, had estrogenic transcriptional activity. Interestingly, both PD98059 and U0126 potentiated E2-induced estrogenic transcriptional activity in KS483 cells, which is opposite to the response in MCF7 breast cancer cells. Our data indicate that the cross-talk between growth factors and estrogen receptor (ER)mediated pathways in KS483 cells is different from that in MCF7 cells. In summary, the differential effects of PD98059 and U0126 indicate their actions are not exclusively due to an inhibition of MAPK pathway. Caution should be taken in the interpretation of the results obtained using these inhibitors. J. Cell. Biochem.(C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:525 / 533
页数:9
相关论文
共 31 条
[1]   Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation [J].
Adams, M ;
Montague, CT ;
Prins, JB ;
Holder, JC ;
Smith, SA ;
Sanders, L ;
Digby, JE ;
Sewter, CP ;
Lazar, MA ;
Chatterjee, VKK ;
O'Rahilly, S .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) :3149-3153
[2]   Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site [J].
Adams, M ;
Reginato, MJ ;
Shao, DL ;
Lazar, MA ;
Chatterjee, VK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) :5128-5132
[3]  
Ahn NG, 2001, METHOD ENZYMOL, V332, P417
[4]   PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[5]   MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance [J].
Atanaskova, N ;
Keshamouni, VG ;
Krueger, JS ;
Schwartz, JA ;
Miller, F ;
Reddy, KB .
ONCOGENE, 2002, 21 (25) :4000-4008
[6]   Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade [J].
Aubert, J ;
Dessolin, S ;
Belmonte, N ;
Li, M ;
McKenzie, FR ;
Staccini, L ;
Villageois, P ;
Barhanin, B ;
Vernallis, A ;
Smith, AG ;
Ailhaud, G ;
Dani, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (35) :24965-24972
[7]   Bone marrow stromal stem cells: Nature, biology, and potential applications [J].
Bianco, P ;
Riminucci, M ;
Gronthos, S ;
Robey, PG .
STEM CELLS, 2001, 19 (03) :180-192
[8]  
Camp HS, 1997, J BIOL CHEM, V272, P10811
[9]   PTHrP inhibits adipocyte differentiation by down-regulating PPARγ activity via a MAPK-dependent pathway [J].
Chan, GK ;
Deckelbaum, RA ;
Bolivar, I ;
Goltzman, D ;
Karaplis, AC .
ENDOCRINOLOGY, 2001, 142 (11) :4900-4909
[10]  
Cuenda A, 2000, METH MOL B, V99, P161